Showing results (11-20 of 71) with videos related to
Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|January 31, 2003
Therapeutic potential of protease-activated receptor-1 antagonistsClaudia K Derian, Bruce E Maryanoff, Han-Cheng Zhang, et al.Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 20, 2004
Discovery of potent peptide-mimetic antagonists for the human thrombin receptor, protease-activated receptor-1 (PAR-1)Bruce E Maryanoff, Han-Cheng Zhang, Patricia Andrade-Gordon, et al.Chemical Biology & Drug Design|September 27, 2006
Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamidesRichard P Shank, David F McComsey, Virginia L Smith-Swintosky, et al.Journal of Medicinal Chemistry|June 9, 2006
Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurementsAlexandra L Klinger, David F McComsey, Virginia Smith-Swintosky, et al.Cardiovascular Drug Reviews|December 4, 2003
RWJ-58259: a selective antagonist of protease activated receptor-1Bruce P Damiano, Claudia K Derian, Bruce E Maryanoff, et al.Organic Letters|November 25, 2003
Cobalt-mediated macrocyclizations. Facile synthesis of 2-oxo pyridinophanes via [2 + 2 + 2] cycloaddition of alpha, omega-diynes and isocyanatesLlorente V R Boñaga, Han-Cheng Zhang, Diane A Gauthier, et al.Journal of the American Chemical Society|August 28, 2013
Mimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructsYannan Zhao, Tomohiro Imura, Luke J Leman, et al.Journal of Medicinal Chemistry|March 18, 2005
Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platformBruce E Maryanoff, David F McComsey, Michael J Costanzo, et al.Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3Han-Cheng Zhang, Llorente V R Boñaga, Hong Ye, et al.Therapeutic Drug Monitoring|May 27, 2003
Analysis of topiramate and its metabolites in plasma and urine of healthy subjects and patients with epilepsy by use of a novel liquid chromatography-mass spectrometry assayMalka Britzi, Stefan Soback, Nina Isoherranen, et al.Pageof 8